1. Home
  2. BIO vs GGB Comparison

BIO vs GGB Comparison

Compare BIO & GGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$319.48

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Logo Gerdau S.A.

GGB

Gerdau S.A.

HOLD

Current Price

$3.69

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
GGB
Founded
1952
1901
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Steel/Iron Ore
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.1B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
BIO
GGB
Price
$319.48
$3.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$358.50
$3.80
AVG Volume (30 Days)
156.6K
12.5M
Earning Date
10-29-2025
10-30-2025
Dividend Yield
N/A
2.79%
EPS Growth
N/A
N/A
EPS
N/A
0.28
Revenue
$2,557,500,000.00
$13,079,666,170.00
Revenue This Year
$1.89
$5.96
Revenue Next Year
$2.45
$4.68
P/E Ratio
N/A
$11.96
Revenue Growth
N/A
7.37
52 Week Low
$211.43
$2.27
52 Week High
$373.69
$3.71

Technical Indicators

Market Signals
Indicator
BIO
GGB
Relative Strength Index (RSI) 52.57 65.07
Support Level $298.35 $3.50
Resistance Level $328.07 $3.62
Average True Range (ATR) 10.38 0.07
MACD 0.29 0.01
Stochastic Oscillator 60.79 92.88

Price Performance

Historical Comparison
BIO
GGB

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutors, mechanical construction bars, and reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives the majority of its revenue from the Brazil Operations segment.

Share on Social Networks: